Health Risk Factor Week
Susan Hasty, Publisher
Table of Contents . . . April 12th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Health Risk Factor Week | Other Publications
American College Health Association - College group issues meningococcal disease immunization recommendations
Center for Disease Control and Prevention - Scientists study the basis of resistance to capreomycin
Columbia University - New findings in allergy medicine described
Indian Health Service, Phoenix - Family practitioners are armed with the tools they need to combat diabetes
The Wall Street Journal Online - Survey shows many second medical opinions result in different treatments
Accelr8 Technology Corp. - Medical instrumentation maker reports loss of $0.03 per share
Accelrys, Inc. - Analyst initiates coverage of nanotechnology firm with a buy rating
Advanced Biotherapy, Inc. - U.S. patent issued for treatment of AIDS
Aeterna Zentaris Inc. - Development of treatment for benign prostate hyperplasia to continue in Japan
Agilent Technologies, Inc. - Lab device firms extend mass spectrometry agreement
Albert Einstein Medical Center, Philadelphia - Atrial tachycardia are curable by radiofrequency ablation
All-India Institute of Medical Science - No increase in incidence of PCNSL cases in India over past 24 years detected
Alnylam Pharmaceuticals, Inc. - In vivo efficacy data presented from Alnylam RSV program at AAAAI meeting
Altana AG - Pharmaceutical firm reports 8% increase in sales
American Academy of Orthopaedic Surgeons - Orthopedic surgeons group gives advice on avoiding injuries at home
American Bio Medica Corp. - Biotech company appoints master distributor
American Council for Fitness and Nutrition - National organizations launch panel discussion series
Anderson Orthopedic Research Institute - Coordinate modular revision knee prosthesis evaluated
Angeion Corporation - Agreement signed to supply metabolic measurement technology to fitness clubs
Aristotle University of Thessaloniki - M RNA of Balkan Crimean-Congo hemorrhagic fever virus strain characterized
Artes Medical, Inc. - Pharmaceutical firm appoints new VP, regulatory affairs, quality assurance
Astralis, Ltd. - Phase II study of Psoraxine for psoriasis does not meet primary endpoint
Australian National University - Sensitive strains of malaria re-emerging subsequent to cholorquine suspension
Autonomous University of Barcelona - Polyimide electrode-induced axonal regeneration characterized
Aviva Systems Biology - ChIP-GLAS launched for simultaneous detection of 20,000 human promoters
Babraham Institute, Cambridge - Calcium signals are determined by interplay of subcellular management systems
Ben Gurion University of Negev - Reports describe recent advances in oncology research
Berlex, Inc. - Drug regulating agency rules Yasmin may be taken by competing female athletes
Best Practices, LLC - Pharmaceutical co-promotions depend on overcoming differences
BioLineRx, Ltd. - Technology licensed from Galmed for treatment of fatty liver disease
Boston University - College alcohol problems exceed previous estimates
Brigham Young University - Formal monitoring methods should be used to identify clients failing treatment
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
